These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1363319)

  • 1. Search for enteric microbial pathogens in patients with ulcerative colitis.
    Brown WJ; Hudson MJ; Patrick S; Matthews SC; Hill MJ; Gent AE; Grace RH; Hellier MD; Swarbrick ET
    Digestion; 1992; 53(3-4):121-8. PubMed ID: 1363319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clostridium difficile, sulphasalazine, and ulcerative colitis.
    Burke DA; Axon AT
    Postgrad Med J; 1987 Nov; 63(745):955-7. PubMed ID: 2897683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Faecal flora of patients with ulcerative colitis during treatment with salicylazosulphapyridine.
    Cooke EM
    Gut; 1969 Jul; 10(7):565-8. PubMed ID: 4390007
    [No Abstract]   [Full Text] [Related]  

  • 4. [Role of Clostridium difficile infection in the relapse of ulcerative colitis].
    Vilalta Castel E; Alcázar Montero MS; Navarro Gaspar C; Gimeno Aranguez M
    An Med Interna; 2002 Dec; 19(12):637-9. PubMed ID: 12593034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of Clostridium difficile toxin in inflammatory bowel disease.
    Rolny P; Järnerot G; Möllby R
    Scand J Gastroenterol; 1983 Jan; 18(1):61-4. PubMed ID: 6144171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulphasalazine treatment and the colorectal mucosa-associated flora in ulcerative colitis.
    Hartley MG; Hudson MJ; Swarbrick ET; Grace RH; Gent AE; Hellier MD
    Aliment Pharmacol Ther; 1996 Apr; 10(2):157-63. PubMed ID: 8730244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of intestinal microflora. V. Fecal microbial ecology in ulcerative colitis and regional enteritis: relationship to severity of disease and chemotherapy.
    Gorbach SL; Nahas L; Plaut AG; Weinstein L; Patterson JF; Levitan R
    Gastroenterology; 1968 Apr; 54(4):575-87. PubMed ID: 4385122
    [No Abstract]   [Full Text] [Related]  

  • 8. Proceedings: Effects of sulphasalazine (Salazopyrin) on faecal flora in patients with inflammatory bowel disease.
    Lendrum R; Walker JG; West B; Hill MJ
    Gut; 1974 Apr; 15(4):344. PubMed ID: 4151868
    [No Abstract]   [Full Text] [Related]  

  • 9. Properties of strains of Escherichia coli carried in different phases of ulcerative colitis.
    Cooke EM; Ewins SP; Hywel-Jones J; Lennard-Jones JE
    Gut; 1974 Feb; 15(2):143-6. PubMed ID: 4595080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term clinical outcomes and factors predictive of relapse after 5-aminosalicylate or sulfasalazine therapy in patients with mild-to-moderate ulcerative colitis.
    Lee HJ; Jung ES; Lee JH; Hong SP; Kim TI; Kim WH; Cheon JH
    Hepatogastroenterology; 2012; 59(117):1415-20. PubMed ID: 22683958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of faecal carriage of Clostridium difficile in patients with ulcerative colitis using real time polymerase chain reaction.
    Balamurugan R; Balaji V; Ramakrishna BS
    Indian J Med Res; 2008 May; 127(5):472-7. PubMed ID: 18653911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ulcerative colitis in Thailand: a clinical study and long term follow-up.
    Pongprasobchai S; Manatsathit S; Leelakusolvong S; Sattawatthamrong Y; Boonyapisit S
    J Med Assoc Thai; 2001 Sep; 84(9):1281-8. PubMed ID: 11800302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional alterations of the microflora in patients with ulcerative colitis.
    Benno P; Leijonmarck CE; Monsén U; Uribe A; Midtvedt T
    Scand J Gastroenterol; 1993 Sep; 28(9):839-44. PubMed ID: 7901893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection with Toxin A-Negative, Toxin B-Negative, Binary Toxin-Positive Clostridium difficile in a Young Patient with Ulcerative Colitis.
    Androga GO; Hart J; Foster NF; Charles A; Forbes D; Riley TV
    J Clin Microbiol; 2015 Nov; 53(11):3702-4. PubMed ID: 26354812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance of remission in ulcerative colitis. Effect of an orally absorbed mast cell stabilizer.
    Davies PS; Rhodes J; Counsell B; Evans BK
    Am J Gastroenterol; 1980 Aug; 74(2):150-3. PubMed ID: 6108711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clostridium difficile toxin in chronic idiopathic colitis.
    Lee DK; Cooper BT; Barbezat GO
    N Z Med J; 1986 Aug; 99(808):620-2. PubMed ID: 2875426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The therapeutic efficacy of 6-mercaptopurine in refractory ulcerative colitis.
    Adler DJ; Korelitz BI
    Am J Gastroenterol; 1990 Jun; 85(6):717-22. PubMed ID: 1972315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current insight into enteropathogens in flare-up ulcerative colitis. An observational study.
    Hassan EA; Abdel Rehim ASE; Ahmed AO; Salim SMAE; Soliman AMA; Rashed HG; Abd El-Kareem DM
    Eur J Gastroenterol Hepatol; 2023 Jul; 35(7):711-720. PubMed ID: 37161967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of effect on faecal microflora of long-term supplementation of dietary fibres in juvenile ulcerative colitis.
    Ejderhamn J; Nord CE; Strandvik B
    Int J Clin Pharmacol Res; 1991; 11(5):247-52. PubMed ID: 1667648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.